Mangalam Drugs & Organics Limited share price

NSE: MANGALAM · ISIN INE584F01014

Key numbers

Market cap
₹ 50.4 Cr
Current price
₹ 31.83
52-week high / low
₹ 74 / 23
Stock P/E
-
Book value
₹ 65.1
Dividend yield
0.00%
ROCE
-15.7%
ROE
-35.2%
Debt to equity
1.09
Sales growth (3 yrs)
-14.3%
Profit growth (3 yrs)
-
1-year return
-57.4%

About Mangalam Drugs & Organics Limited

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate. It also provides intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-dichloro-5-methoxy pyrimidine; 4,7 dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base; and tenofovir disoproxil base. In addition, the company offers specialty chemicals comprising menthol; 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione; and 4-cynoethyl-2-methy phenol. Further, it offers organic and inorganic chemicals and heavy chemicals; and offers active…

Quarterly results

Consolidated figures in ₹ crores

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales5749586757
Operating profit-5-3-1-61
Net profit-14-7-10-13-8
EPS (₹)-8.72-4.64-6.21-8.48-4.83

Peers in Drug Manufacturers - Specialty & Generic

Data for information only, not investment advice. Prices end of day.